跳至主要内容
临床试验/jRCTs071200031
jRCTs071200031招募中不适用

Clinical trial about the influence of royal jelly oral intake for endothelial cell function in patients with hemodialysis: Double blind, randomized trial focused on oxidative stress, macrophage activity, and cancer stem cell

未提供0 个研究点目标入组 270 人开始时间: 2020年12月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
270
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Prevention Purpose
盲法
Double Blind

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • •Hemodialysis caused by chronic renal failure
  • •Over 24 months survival after the treatment is expected.
  • •Performance status is 0 -
  • •Age is 20 years and more.
  • •Informed consent was obtained by the patient.
  • •Understanding of the facts that all examinations, procedure, and treatments caused by hemodialysis were performed by Japan medical care, and that there is no compensation about the symptoms, disease and disorders in this trial.

排除标准

  • •Have already intake of royal jelly or bee-original foods
  • •Have plan to buy and take of royal jelly in future
  • •Have complication of severe blood diseases that are needed the treatment.
  • •Have allergy against royal jelly or bee-original foods
  • •Have a history of asthma and atopic disease
  • •During pregnancy or breast-feeding
  • •Principle investigator or co-investigators judged as inappropriate for this study.

结局指标

主要结局

-

Levels of flow mediated dilation at 0 and 24 months after stating of the treatment

次要结局

未报告次要终点

研究者

发起方
未提供

相似试验